Bioactive components of functional foods from vegetable origin;Componentes bioactivos de alimentos funcionales de origen vegetal

Revista Mexicana de Ciencias Farmaceuticas

Volumn 37, Issue 4, 2006, Pages 58-68

  Serrano, Maria Elisa Drago ^a   López, Marisol López ^a   Espuñes, Teresita Del Rosario Saínz ^a  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

Functional foods; Nutritional therapy; Phytochemicals

Indexed keywords

EID: 67649460691     PISSN: 10273956     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Foster B.C., Arnason J.T., Briggs C.J. 2005. Natural health products and drug disposition. Annual Review of Pharmacology and Toxicology, 45:203-226. (Pubitemid 40261803)
2. Jones P.J. 2002. Clinical nutrition: 7. Functional foods more than just nutrition. Canadian Medical Association Journal, 166 (12):1555-1563. (Pubitemid 34634379)
3. Roberfroid M.B. 1999. Concepts in Functional foods: the case of inulin and oligofructose. Journal of Nutrition, 129 (7 Suppl):1398S-1401S. (Pubitemid 29302765)
4. Mattila P., Kumpulainen J. 2002. Determination of free and total phenolic acids in plant-derived food by HPLC with diode-array detection. Journal of Agriculture and Food Chemistry, 50(13): 3660-3667. (Pubitemid 34640687)
5. Milner J.A. 2004. Molecular targets for bioactive food components. Journal of Nutrition, 134(9):2492S-2498S. (Pubitemid 39201626)
6. Krizkova L., Nagy M., Polonyi J., Dobias J., Belicova A., Grancai D., Krajcovic J. 2000. Phenolic acids inhibit chloroplast mutagenesis in Euglena gracilis. Mutation Research, 469 (1): 107-1104
7. Yeh C.T., Yen G.C. 2003. Effects of phenolic acids on human phenolsulfotranferases in relation to their antioxidant activity. Journal of Agriculture and Food Chemistry, 51(5): 1474-1479.
8. Puupponen-Pimiä R., Nohynek L., Meier C., Kähkönen M., Heinonen M., Hopia A.,Oksman-Caldentey K.M. 2001. Antimicrobial properties of phenolic compounds from berries. Journal of Applied Microbiology, 90 (4): 494-507. (Pubitemid 32291248)
9. Kerry N.L., Abbey M. 1997. Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis, 35 (1): 93-102. (Pubitemid 27469700)
10. Osawa T. 1999. Protective role of rice polyphenols in oxidative stress. Anticancer Research, 19 (5A): 3645-3650.
11. Morton L.W., Abu-Amsha Caccetta R., Puddey I.B., Croft K.D. 2000. Chemistry and biological effects of dietary phenolic compounds: relevance to cardiovascular disease. Clinical and Experimental Pharmacology and Physiology, 27(3): 152-159. (Pubitemid 30158926)
12. Gee J.M., Johnson I.T. 2001. Polyphenolic compounds: interactions with the gut and implications for human health. Current Medicinal Chemistry, 8 (11): 1245-1255. (Pubitemid 32791795)
13. Nijveltd R.J., van Nood E., van Hoorn D. E.C., Boelens P.G., van Norren K., van Leewen P.A.M. 2001. Flavonoids: a review of probable mechanisms of action and potential applications. The American Journal of Clinical Nutrition, 74 (4):418-425. (Pubitemid 32880250)
14. Theoharides T.C. , Bielory L. 2004. Mast cells and mast cell mediators as targets of dietary supplements. Annals of Allergy, Asthma and Immunology, 93 (2 Suppl 1):S24-S34.
15. Barnes S., Prasain J. 2005. Current progress in the use of traditional medicines and nutraceuticals. Current Opinion in Plant Biology, 8(3): 324-328. (Pubitemid 40599986)
16. Branca F., Lorenzetti S. 2005. Health effects of phytoestrogens. Forum of Nutrition, 57:100-111. (Pubitemid 43265040)
17. Ganry O. 2005. Phytoestrogens and prostate cancer risk. Preventive Medicine, 41(1):1-6. (Pubitemid 40762576)
18. Dixon R.A. 2004. Phytoestrogens. Annual Review of Plant Biology, 55:225-261.
19. Dijsselbloem N., Vanden Berghe M., De Naeyer A., Haegeman G. 2004. Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anticancer and anti-inflammatory therapy. Biochemical Pharmacology, 68(6): 1171-1185.
20. Bhathena S.J., Velasquez M.T. 2002. Beneficial role of dietary phyestrogens in obesity and diabetes. The American Journal of Clinical Nutrition, 76(6): 1191-1201. (Pubitemid 35416551)
21. Stuchĺk M., Stanislav Žák. 2002. Vegetable lipids as components of functional foods. Biomedical Papers of the Medical Faculty of the University Palacky Olomouc Czechoslovakia, 146(2):3-10.
22. Halsted C.H. 2003. Dietary supplements and functional foods: 2 sides of a coin? The American Journal of Clinical Nutrition, 77(Suppl):1001S-1007S.
23. Moreau R.A., Whitaker B.D., Hicks K.B. 2002. Phytosterols, phystanols, and their conjugates in foods: structural diversity, quantitative analysis, and health promoting uses. Progress in Lipid Research, 41(6): 457-500. (Pubitemid 34886556)
24. Gylling H., Miettinen T.A. 2005. The effect of plant stanol and sterol enriched foods on lipid metabolism, serum lipids and coronary heart disease. Annals of Clinical Biochemistry, 42(Pt 4):254-1253 (Pubitemid 40961742)
25. Bouic P.J. 2001. The role of phytosterols and phytosterolins in immune modulation: a review of the past 10 years. Current Opinion in Clinical Nutrition and Metabolic Care, 4(6): 471-475. (Pubitemid 34755401)
26. Kerckhoffs D.A.J.M., Brouns F., Hornstra G., Mensink R.P. 2002. Effects on the human serum lipoprotein profile of β-glucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrienols. Journal of Nutrition, 132(9): 2494-2505. (Pubitemid 35013225)
27. Normen L., Shaw C.A., Fink C.S., Awad A.B. 2004. Combination of phytosterols and omega-3 fatty acids: a potential strategy to promote cardiovascular health. Current Medicinal Chemistry Cardiovascular and Hematological Agents, 2(1):1-12. (Pubitemid 38854964)
28. Larsson S.C., Kumlin M., Ingelman-Sundberg M., Wolk A. 2004. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. The American Journal of Clinical Nutrition, 79(6):935-945. (Pubitemid 41095944)
29. Cummings J., Bingham S, Heaton K., Eastwood M. 1992. Fecal weight, colon cancer risk and dietary intake of nonstarch polysaccharide (diet fiber). Gastroenterology, 103 (6): 1783-1787.
30. Pick M.E., Hawrysh Z.J., Gee M.I., Toth E., Garg M.L., Hardin R.T. 1996. Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. Journal of American Dietetic Association, 96(12):1254-1261. (Pubitemid 27381748)
31. Keogh G.F., Cooper G.J.S., Mulvey T.B., McArdle B. H., Coles G. D., Monro J. A., Poppitt S. D. 2003. Randomized controlled crossover study of the effect of a highly glucan enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. The American Journal of Clinical Nutrition, 78(4):711-718.
32. Wursch P., Pi-Sunyer F.X. 1997. The role of viscous fiber in the metabolic control of diabetes. A review with special emphasis on cereals rich in beta-glucan. Diabetes Care, 20(11): 1774-1780.
33. Dwyer J. 1995. Overview: dietary approaches for reducing cardiovascular disease risks. Journal of Nutrition, 125 (3 Suppl):656S-665S.
34. Borek C. 2001. Antioxidant health effects of aged garlic extract. Journal of Nutrition, 131 (3S): 1010S-1015S. (Pubitemid 32194999)
35. Amagase H., Petesch B.L., Matsuura H., Kasuga S., Itakura Y. 2001. Intake of garlic and its bioactive components. Journal of Nutrition, 131 (3S): 955S-962S. (Pubitemid 32194988)
36. Okada T., Tanaka K., Fujita I., Sato E., Okajima H. 2005. Antioxidant activity of thiosulfinates derived from garlic. Redox Report Communications in Free Radical Research, 10(2):96-102. (Pubitemid 44110217)
37. Hecht S.S. 1999. Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. Journal of Nutrition, 129 (3):768S-774S. (Pubitemid 29118065)
38. Munday R., Munday C.M. 2002. Selective induction of phase II enzymes in the urinary bladder of rats by allyl isothiocyanate, a compound derived from Brassica vegetables. Nutrition and Cancer, 44 (1):52-59. (Pubitemid 36359320)
39. Fimognari C., Nüsse M., Berti F., Iori R., Cantelli-Forti G., Hrelia P. 2004. Isothiocyanates as novel cytotoxic and cytostatic agents: molecular pathway on human transformed and non transformed cells. Biochemical Pharmacology, 68(6):1133-1138. (Pubitemid 39094278)
40. Haristoy X., Fahey J.W., Scholtus I., Lozniewski A. 2005. Evaluation of the antimicrobial effects of several isothiocyanates on Helicobacter pylori. Planta Medica, 71(4): 326-330. (Pubitemid 40676456)
41. Okazaki K., Umemura T., Imazawa T., Nishikawa A., Masegi T., Hirose M. 2003. Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl) nitrosamine in rats after initiation. Cancer Science, 94(11): 948-952. (Pubitemid 37508976)
42. Crowell P.L. 1999. Prevention and therapy of cancer by dietary monoterpenes. Journal of Nutrition, 129 (3):775S-778S. (Pubitemid 29118066)
43. Crowell P.L., Gould M.N. 1994. Chemoprevention and therapy of cancer by d-limonene. Critical Reviews in Oncogenesis, 5(1):1-22. (Pubitemid 2125282)
44. Trombetta D., Castelli F., Sarpietro M.G., Venuti V., Cristani M., Daniele C., Saija A., Mazzanti G., Bisignano G. 2005. Mechanisms of antibacterial action of three monoterpenes. Antimicrobial Agents and Chemotherapy, 49(6):2474-2478. (Pubitemid 40734482)